Few of the notable companies operating in the market are
Helioscopie Medical Implants
These leaders adopt strategies such as novel product launch, mergers and acquisitions to influence business in industry of intragastric balloon.
Frequently Asked Questions (FAQ) :
The global market size of intragastric balloon surpassed $34 million in 2021 and is expected to record a strong CAGR of more than 13.4% during the forecast period of 2022-2028.
The single intragastric balloon segment accounted for $23.2 million in 2021 as the demand for non-invasive surgeries is growing and several technological advancements are being introduced in these products to help obese patients better manage their condition.
Saline-filled intragastric balloons occupied over 63% of the market share in 2021 as there are several advantages of using these balloons, such as ability to reduce weight more effectively and faster detection of the silicone balloon deflation due to the presence of methylene blue dye.
Hospitals accounted for nearly 35.5% of revenue share in 2021 as new clinical trials are being conducted to help patients diagnosed with obesity explore various experimental therapies to better manage their ailment.
Notable organizations, such as Allurion Technologies, Medsil, Districlass Medical, Apollo Endosurgery, Helioscopie Medical Implants, and Silimed Inc., among many others, are positively influencing the global market forecast.